NCT03290534View on ClinicalTrials.gov

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 13, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Lung CancerLung Cancer Stage ILung Cancer Stage II
Interventions
DEVICE

CivaSheet

implanting CivaSheet for localized radiation dose delivery

Trial Locations (1)

10016

RECRUITING

NYU Langone Health, New York

Sponsors

Lead Sponsor

CivaTech Oncology
All Listed Sponsors
lead

CivaTech Oncology

INDUSTRY